peeyam
- 08 May 2007 11:30
LONDON (AFX) - Provexis PLC said it has entered into a long-term collaboration agreement with Unilever PLC to jointly develop a new concentrated format of its patented Fruitflow heart-health technology for application in Unilever's food product portfolio.
Financial details of the deal were not disclosed.
The partners plan to enter into a global licence arrangement for the technology.
Fruitflow is a patented natural extract from tomato which Provexis said has been shown in human trials to reduce the propensity for aberrant blood clotting that is typically associated with cardiovascular disease and which can lead to heart attack or stroke.
In 2005 the market for heart benefit foods was worth 4 bln usd globally, Provexis added.
Considering the growth potential this share has a target of about 8-10p in the medium tern and is a good buy at current levels
As usual, pls do ur own research.
blanche
- 03 Feb 2010 10:03
- 1016 of 1204
Don`t think it will be tooooooooo long to wait now. getting a lot more coverage in journals, mags and papers now.
required field
- 03 Feb 2010 11:48
- 1017 of 1204
Up again....
Balerboy
- 12 Feb 2010 07:48
- 1018 of 1204
Good news at last:
12 February 2010
Provexis plc
("Provexis" or the "Company")
DSM Nutritional Products and Provexis agree Letter of Intent for Fruitflow Alliance
Provexis plc, the life-science business that discovers, develops and licenses scientifically-proven functional food, medical food and dietary supplement technologies, is pleased to announce it has entered into a Letter of Intent ("LOI") for its Fruitflow technology with DSM Nutritional Products ("DSM").
The LOI provides a framework for the parties to develop a long-term Alliance Agreement (the "Agreement"), giving DSM exclusive global rights to Fruitflow. This Agreement will provide for a partnership and structure in which DSM and Provexis will develop, market and sell Fruitflow as an ingredient in all formats and territories. Profits from the Agreement will be shared by the parties on an agreed basis, linked to various performance milestones. Provexis will continue to support the development of current and future formats of Fruitflow and DSM will contribute with its manufacturing and selling experience and excellence to a successful commercialisation of Fruitflow.
Shareholders should be aware that there can be no guarantee that the Company will enter into an Agreement with DSM. The Board of Directors however are confident that the LOI provides a sufficient framework that allows both parties to enter into a final Agreement in a timely manner.
DSM is classified as a related party of the Company for the purposes of the AIM Rules for Companies (the "AIM Rules"). Accordingly, the letter of intent will be classified as a related party transaction for the purpose of Rule 13 of the AIM Rules. The directors of Provexis (the "Directors"), having consulted with Evolution Securities Limited ("Evolution Securities"), the Company's nominated adviser, consider that the terms of the letter of intent are fair and reasonable insofar as Provexis's shareholders are concerned. In providing advice to the Directors, Evolution Securities has taken into account the Directors' commercial assessments.
Stephen Moon, CEO of Provexis said:
"We are delighted with this important step towards our new Agreement with our strategic partner DSM. We firmly believe that the expertise, scale and reputation of DSM will underpin the commercial success of Fruitflow. DSM has existing relationships with key companies globally in food, beverage and consumer healthcare. This coupled with its substantial sales force made this the best strategic fit for Provexis and will enable us to build Fruitflow into a significant global functional food brand. Provexis and DSM are currently assessing further projects which may develop the scope of the Agreement further."
tabasco
- 12 Feb 2010 07:59
- 1019 of 1204
Looks like a possible good start
halifax
- 12 Feb 2010 13:07
- 1020 of 1204
What happened to the big deal with coca cola?
cynic
- 12 Feb 2010 13:32
- 1021 of 1204
just so many bubbles in the air, at least for now
halifax
- 12 Feb 2010 13:43
- 1022 of 1204
back to 3p then.
cynic
- 12 Feb 2010 13:47
- 1023 of 1204
not if filled with helium (preferably not hydrogen!)
tabasco
- 12 Feb 2010 13:53
- 1024 of 1204
Im forever blowing bubbles!
Balerboy
- 12 Feb 2010 13:58
- 1025 of 1204
nor methane....
ptholden
- 12 Feb 2010 13:59
- 1026 of 1204
Seems PXS has finally settled down after the earlier hysteria which managed to ramp the SP up to an unrealistic level. I do wonder how many got sucked in at much higher levels and are trying to work out whether to take a loss or hang on for the much hyped Coca Cola deal (should it of course ever materialise).
I can't say I have changed my opinion on the prospects of PXS, one or two of these companys come around every year and usually come back to earth with a thud following excessive excitement. 5p looks on the cards, but I guess a half impressive RNS could see it shooting back up again. Reminds me of SEO and their one machine trail with ASDA.
Balerboy
- 12 Feb 2010 14:01
- 1027 of 1204
nor methane.....
toki
- 12 Feb 2010 15:00
- 1028 of 1204
Tippedd on uk analyst. Evils diary:
UK-Analyst.com
ptholden
- 12 Feb 2010 16:01
- 1029 of 1204
Thought he was shorting it? Not that has any particualr relevance
blanche
- 12 Feb 2010 16:09
- 1030 of 1204
Little pi panickers jump. And the big boys mop up!
halifax
- 12 Feb 2010 16:26
- 1031 of 1204
EK has shorted at 8.2p, doing well headed for 3p.
ptholden
- 12 Feb 2010 16:27
- 1032 of 1204
Little PI panickers might well have their heads screwed on straight! Time will tell ;)
blanche
- 13 Feb 2010 18:10
- 1033 of 1204
DAILY EXPRESS TODAY
GOING DUTCH
Health food developer provexis has lined up dutch vitamins giant DSM to market its anti-thrombotic Fruitflow tomato concentrate globally. Provexis boss Stephen Moon, said: "DSM is a very significant player and enjoys companies like coca-cola and unilever as major clients."
ptholden
- 15 Feb 2010 07:04
- 1034 of 1204
Slightly surprised no comments over the weekend, a quite frantic day on Friday elicited by CEO Moon binning 6 million shares, seemingly not demonstrating much confidence in PXS prospects. I would imagine today will be equally volatile.
blanche
- 17 Feb 2010 12:53
- 1035 of 1204
`